nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCB11—Vincristine—colon cancer	0.263	0.314	CbGbCtD
Fluorescein—ABCC1—Irinotecan—colon cancer	0.214	0.255	CbGbCtD
Fluorescein—ABCC1—Vincristine—colon cancer	0.187	0.223	CbGbCtD
Fluorescein—ABCC1—Methotrexate—colon cancer	0.113	0.135	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—colon cancer	0.0612	0.0731	CbGbCtD
Fluorescein—ABCB11—bile—colon cancer	0.0236	0.658	CbGeAlD
Fluorescein—Dysphasia—Capecitabine—colon cancer	0.00473	0.0373	CcSEcCtD
Fluorescein—Urine color abnormal—Capecitabine—colon cancer	0.00438	0.0346	CcSEcCtD
Fluorescein—Peripheral vascular disorder—Irinotecan—colon cancer	0.00315	0.0248	CcSEcCtD
Fluorescein—Vasospasm—Capecitabine—colon cancer	0.00302	0.0238	CcSEcCtD
Fluorescein—Chromaturia—Capecitabine—colon cancer	0.00289	0.0228	CcSEcCtD
Fluorescein—ABCB11—digestive system—colon cancer	0.00258	0.0719	CbGeAlD
Fluorescein—ABCB11—liver—colon cancer	0.00192	0.0536	CbGeAlD
Fluorescein—Sneezing—Capecitabine—colon cancer	0.00186	0.0147	CcSEcCtD
Fluorescein—Extravasation—Vincristine—colon cancer	0.00182	0.0143	CcSEcCtD
Fluorescein—Extravasation—Irinotecan—colon cancer	0.00177	0.0139	CcSEcCtD
Fluorescein—Vasodilation—Irinotecan—colon cancer	0.00176	0.0138	CcSEcCtD
Fluorescein—Vasodilation procedure—Irinotecan—colon cancer	0.00176	0.0138	CcSEcCtD
Fluorescein—Extravasation—Fluorouracil—colon cancer	0.00169	0.0134	CcSEcCtD
Fluorescein—Respiratory failure—Vincristine—colon cancer	0.00161	0.0127	CcSEcCtD
Fluorescein—Aphasia—Capecitabine—colon cancer	0.00159	0.0126	CcSEcCtD
Fluorescein—Neoplasm—Irinotecan—colon cancer	0.00139	0.011	CcSEcCtD
Fluorescein—Thrombophlebitis—Irinotecan—colon cancer	0.00129	0.0102	CcSEcCtD
Fluorescein—Thrombophlebitis—Fluorouracil—colon cancer	0.00124	0.00977	CcSEcCtD
Fluorescein—Hypoxia—Methotrexate—colon cancer	0.00121	0.00954	CcSEcCtD
Fluorescein—CYP1A1—epithelium—colon cancer	0.0012	0.0333	CbGeAlD
Fluorescein—Aphasia—Methotrexate—colon cancer	0.00118	0.00935	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Irinotecan—colon cancer	0.00116	0.00913	CcSEcCtD
Fluorescein—Skin discolouration—Capecitabine—colon cancer	0.00114	0.00902	CcSEcCtD
Fluorescein—Cerebrovascular accident—Irinotecan—colon cancer	0.00114	0.00901	CcSEcCtD
Fluorescein—CYP1A1—renal system—colon cancer	0.00111	0.0309	CbGeAlD
Fluorescein—Cardiac arrest—Vincristine—colon cancer	0.00109	0.00862	CcSEcCtD
Fluorescein—Cardiac arrest—Irinotecan—colon cancer	0.00106	0.0084	CcSEcCtD
Fluorescein—ABCC1—vagina—colon cancer	0.00102	0.0284	CbGeAlD
Fluorescein—Cardiac arrest—Fluorouracil—colon cancer	0.00102	0.00804	CcSEcCtD
Fluorescein—Angina pectoris—Irinotecan—colon cancer	0.000943	0.00744	CcSEcCtD
Fluorescein—Neoplasm—Capecitabine—colon cancer	0.000933	0.00736	CcSEcCtD
Fluorescein—CYP1A1—digestive system—colon cancer	0.000909	0.0253	CbGeAlD
Fluorescein—Angina pectoris—Fluorouracil—colon cancer	0.000903	0.00712	CcSEcCtD
Fluorescein—Extravasation—Methotrexate—colon cancer	0.000881	0.00695	CcSEcCtD
Fluorescein—Thrombophlebitis—Capecitabine—colon cancer	0.000866	0.00683	CcSEcCtD
Fluorescein—ABCC1—liver—colon cancer	0.000862	0.024	CbGeAlD
Fluorescein—Skin discolouration—Methotrexate—colon cancer	0.000851	0.00671	CcSEcCtD
Fluorescein—CYP1A1—vagina—colon cancer	0.000803	0.0224	CbGeAlD
Fluorescein—Hot flush—Capecitabine—colon cancer	0.000801	0.00632	CcSEcCtD
Fluorescein—Menopausal symptoms—Capecitabine—colon cancer	0.000794	0.00627	CcSEcCtD
Fluorescein—Hypoaesthesia—Vincristine—colon cancer	0.000791	0.00624	CcSEcCtD
Fluorescein—Bradycardia—Irinotecan—colon cancer	0.000789	0.00622	CcSEcCtD
Fluorescein—Respiratory failure—Methotrexate—colon cancer	0.000783	0.00617	CcSEcCtD
Fluorescein—Cerebrovascular accident—Capecitabine—colon cancer	0.000765	0.00603	CcSEcCtD
Fluorescein—Cardiac disorder—Vincristine—colon cancer	0.000738	0.00582	CcSEcCtD
Fluorescein—Hypoaesthesia—Fluorouracil—colon cancer	0.000738	0.00582	CcSEcCtD
Fluorescein—Angiopathy—Vincristine—colon cancer	0.000722	0.00569	CcSEcCtD
Fluorescein—Cardiac disorder—Irinotecan—colon cancer	0.000719	0.00567	CcSEcCtD
Fluorescein—Mediastinal disorder—Vincristine—colon cancer	0.000717	0.00566	CcSEcCtD
Fluorescein—Cardiac arrest—Capecitabine—colon cancer	0.000713	0.00562	CcSEcCtD
Fluorescein—Angiopathy—Irinotecan—colon cancer	0.000703	0.00554	CcSEcCtD
Fluorescein—Immune system disorder—Irinotecan—colon cancer	0.0007	0.00552	CcSEcCtD
Fluorescein—Mediastinal disorder—Irinotecan—colon cancer	0.000698	0.00551	CcSEcCtD
Fluorescein—Chills—Irinotecan—colon cancer	0.000695	0.00548	CcSEcCtD
Fluorescein—Neoplasm—Methotrexate—colon cancer	0.000695	0.00548	CcSEcCtD
Fluorescein—Pulmonary oedema—Methotrexate—colon cancer	0.000684	0.0054	CcSEcCtD
Fluorescein—CYP1A1—liver—colon cancer	0.000677	0.0189	CbGeAlD
Fluorescein—ABCC1—lymph node—colon cancer	0.000661	0.0184	CbGeAlD
Fluorescein—Asthma—Capecitabine—colon cancer	0.000648	0.00511	CcSEcCtD
Fluorescein—Erythema—Fluorouracil—colon cancer	0.000646	0.00509	CcSEcCtD
Fluorescein—Thrombophlebitis—Methotrexate—colon cancer	0.000644	0.00508	CcSEcCtD
Fluorescein—Bronchospasm—Capecitabine—colon cancer	0.000637	0.00503	CcSEcCtD
Fluorescein—Angina pectoris—Capecitabine—colon cancer	0.000631	0.00498	CcSEcCtD
Fluorescein—Ill-defined disorder—Irinotecan—colon cancer	0.000626	0.00494	CcSEcCtD
Fluorescein—Abdominal discomfort—Capecitabine—colon cancer	0.000621	0.0049	CcSEcCtD
Fluorescein—Malaise—Irinotecan—colon cancer	0.000608	0.0048	CcSEcCtD
Fluorescein—Syncope—Irinotecan—colon cancer	0.000605	0.00477	CcSEcCtD
Fluorescein—Convulsion—Vincristine—colon cancer	0.0006	0.00473	CcSEcCtD
Fluorescein—Hypertension—Vincristine—colon cancer	0.000598	0.00472	CcSEcCtD
Fluorescein—Loss of consciousness—Irinotecan—colon cancer	0.000593	0.00468	CcSEcCtD
Fluorescein—Cough—Irinotecan—colon cancer	0.000588	0.00464	CcSEcCtD
Fluorescein—Hypertension—Irinotecan—colon cancer	0.000582	0.00459	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Methotrexate—colon cancer	0.000576	0.00455	CcSEcCtD
Fluorescein—Cerebrovascular accident—Methotrexate—colon cancer	0.000569	0.00449	CcSEcCtD
Fluorescein—Discomfort—Irinotecan—colon cancer	0.000567	0.00447	CcSEcCtD
Fluorescein—Oedema—Vincristine—colon cancer	0.000565	0.00446	CcSEcCtD
Fluorescein—Anaphylactic shock—Vincristine—colon cancer	0.000565	0.00446	CcSEcCtD
Fluorescein—Convulsion—Fluorouracil—colon cancer	0.00056	0.00441	CcSEcCtD
Fluorescein—Nervous system disorder—Vincristine—colon cancer	0.000554	0.00437	CcSEcCtD
Fluorescein—Anaphylactic shock—Irinotecan—colon cancer	0.00055	0.00434	CcSEcCtD
Fluorescein—Oedema—Irinotecan—colon cancer	0.00055	0.00434	CcSEcCtD
Fluorescein—Chest pain—Fluorouracil—colon cancer	0.00055	0.00434	CcSEcCtD
Fluorescein—Hyperhidrosis—Vincristine—colon cancer	0.000546	0.00431	CcSEcCtD
Fluorescein—Discomfort—Fluorouracil—colon cancer	0.000543	0.00429	CcSEcCtD
Fluorescein—Shock—Irinotecan—colon cancer	0.000541	0.00427	CcSEcCtD
Fluorescein—Nervous system disorder—Irinotecan—colon cancer	0.00054	0.00426	CcSEcCtD
Fluorescein—Hyperhidrosis—Irinotecan—colon cancer	0.000532	0.0042	CcSEcCtD
Fluorescein—Hypotension—Vincristine—colon cancer	0.000528	0.00417	CcSEcCtD
Fluorescein—Bradycardia—Capecitabine—colon cancer	0.000528	0.00416	CcSEcCtD
Fluorescein—Anaphylactic shock—Fluorouracil—colon cancer	0.000527	0.00416	CcSEcCtD
Fluorescein—Oedema—Fluorouracil—colon cancer	0.000527	0.00416	CcSEcCtD
Fluorescein—CYP1A1—lymph node—colon cancer	0.000519	0.0145	CbGeAlD
Fluorescein—Nervous system disorder—Fluorouracil—colon cancer	0.000517	0.00408	CcSEcCtD
Fluorescein—Hypoaesthesia—Capecitabine—colon cancer	0.000516	0.00407	CcSEcCtD
Fluorescein—Tachycardia—Fluorouracil—colon cancer	0.000514	0.00406	CcSEcCtD
Fluorescein—Hypotension—Irinotecan—colon cancer	0.000514	0.00406	CcSEcCtD
Fluorescein—Paraesthesia—Vincristine—colon cancer	0.000507	0.004	CcSEcCtD
Fluorescein—Paraesthesia—Irinotecan—colon cancer	0.000494	0.0039	CcSEcCtD
Fluorescein—Hypotension—Fluorouracil—colon cancer	0.000493	0.00389	CcSEcCtD
Fluorescein—Dyspnoea—Irinotecan—colon cancer	0.000491	0.00387	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vincristine—colon cancer	0.000488	0.00385	CcSEcCtD
Fluorescein—Pain—Vincristine—colon cancer	0.000483	0.00381	CcSEcCtD
Fluorescein—Asthma—Methotrexate—colon cancer	0.000482	0.0038	CcSEcCtD
Fluorescein—Cardiac disorder—Capecitabine—colon cancer	0.000481	0.0038	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Irinotecan—colon cancer	0.000475	0.00375	CcSEcCtD
Fluorescein—Paraesthesia—Fluorouracil—colon cancer	0.000473	0.00373	CcSEcCtD
Fluorescein—Pain—Irinotecan—colon cancer	0.000471	0.00371	CcSEcCtD
Fluorescein—Angiopathy—Capecitabine—colon cancer	0.00047	0.00371	CcSEcCtD
Fluorescein—Dyspnoea—Fluorouracil—colon cancer	0.00047	0.00371	CcSEcCtD
Fluorescein—Immune system disorder—Capecitabine—colon cancer	0.000468	0.00369	CcSEcCtD
Fluorescein—Mediastinal disorder—Capecitabine—colon cancer	0.000467	0.00369	CcSEcCtD
Fluorescein—Chills—Capecitabine—colon cancer	0.000465	0.00367	CcSEcCtD
Fluorescein—Abdominal discomfort—Methotrexate—colon cancer	0.000462	0.00365	CcSEcCtD
Fluorescein—Gastrointestinal pain—Vincristine—colon cancer	0.000462	0.00365	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000455	0.00359	CcSEcCtD
Fluorescein—Feeling abnormal—Irinotecan—colon cancer	0.000454	0.00358	CcSEcCtD
Fluorescein—Erythema—Capecitabine—colon cancer	0.000451	0.00356	CcSEcCtD
Fluorescein—Pain—Fluorouracil—colon cancer	0.000451	0.00356	CcSEcCtD
Fluorescein—Gastrointestinal pain—Irinotecan—colon cancer	0.00045	0.00355	CcSEcCtD
Fluorescein—Abdominal pain—Vincristine—colon cancer	0.000447	0.00352	CcSEcCtD
Fluorescein—Dysgeusia—Capecitabine—colon cancer	0.000442	0.00349	CcSEcCtD
Fluorescein—Abdominal pain—Irinotecan—colon cancer	0.000435	0.00343	CcSEcCtD
Fluorescein—Feeling abnormal—Fluorouracil—colon cancer	0.000434	0.00343	CcSEcCtD
Fluorescein—Tremor—Capecitabine—colon cancer	0.000423	0.00334	CcSEcCtD
Fluorescein—Ill-defined disorder—Capecitabine—colon cancer	0.000419	0.0033	CcSEcCtD
Fluorescein—Urticaria—Fluorouracil—colon cancer	0.000419	0.0033	CcSEcCtD
Fluorescein—Hypersensitivity—Vincristine—colon cancer	0.000416	0.00328	CcSEcCtD
Fluorescein—Malaise—Capecitabine—colon cancer	0.000407	0.00321	CcSEcCtD
Fluorescein—Hypersensitivity—Irinotecan—colon cancer	0.000405	0.0032	CcSEcCtD
Fluorescein—Asthenia—Vincristine—colon cancer	0.000405	0.0032	CcSEcCtD
Fluorescein—Syncope—Capecitabine—colon cancer	0.000405	0.00319	CcSEcCtD
Fluorescein—Loss of consciousness—Capecitabine—colon cancer	0.000397	0.00313	CcSEcCtD
Fluorescein—Asthenia—Irinotecan—colon cancer	0.000395	0.00312	CcSEcCtD
Fluorescein—Cough—Capecitabine—colon cancer	0.000394	0.00311	CcSEcCtD
Fluorescein—Hypertension—Capecitabine—colon cancer	0.00039	0.00307	CcSEcCtD
Fluorescein—Hypersensitivity—Fluorouracil—colon cancer	0.000388	0.00306	CcSEcCtD
Fluorescein—Chest pain—Capecitabine—colon cancer	0.000384	0.00303	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000382	0.00301	CcSEcCtD
Fluorescein—Discomfort—Capecitabine—colon cancer	0.00038	0.00299	CcSEcCtD
Fluorescein—Dizziness—Vincristine—colon cancer	0.000374	0.00295	CcSEcCtD
Fluorescein—Pruritus—Fluorouracil—colon cancer	0.000373	0.00294	CcSEcCtD
Fluorescein—Oedema—Capecitabine—colon cancer	0.000368	0.00291	CcSEcCtD
Fluorescein—Dizziness—Irinotecan—colon cancer	0.000364	0.00287	CcSEcCtD
Fluorescein—Shock—Capecitabine—colon cancer	0.000362	0.00286	CcSEcCtD
Fluorescein—Nervous system disorder—Capecitabine—colon cancer	0.000361	0.00285	CcSEcCtD
Fluorescein—Tachycardia—Capecitabine—colon cancer	0.000359	0.00284	CcSEcCtD
Fluorescein—Vomiting—Vincristine—colon cancer	0.000359	0.00283	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—colon cancer	0.000358	0.00283	CcSEcCtD
Fluorescein—Skin disorder—Capecitabine—colon cancer	0.000358	0.00282	CcSEcCtD
Fluorescein—Rash—Vincristine—colon cancer	0.000356	0.00281	CcSEcCtD
Fluorescein—Hyperhidrosis—Capecitabine—colon cancer	0.000356	0.00281	CcSEcCtD
Fluorescein—Dermatitis—Vincristine—colon cancer	0.000356	0.00281	CcSEcCtD
Fluorescein—Headache—Vincristine—colon cancer	0.000354	0.00279	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—colon cancer	0.00035	0.00276	CcSEcCtD
Fluorescein—Vomiting—Irinotecan—colon cancer	0.00035	0.00276	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—colon cancer	0.000349	0.00275	CcSEcCtD
Fluorescein—Dizziness—Fluorouracil—colon cancer	0.000349	0.00275	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—colon cancer	0.000348	0.00274	CcSEcCtD
Fluorescein—Rash—Irinotecan—colon cancer	0.000347	0.00274	CcSEcCtD
Fluorescein—Dermatitis—Irinotecan—colon cancer	0.000347	0.00273	CcSEcCtD
Fluorescein—Chills—Methotrexate—colon cancer	0.000346	0.00273	CcSEcCtD
Fluorescein—Headache—Irinotecan—colon cancer	0.000345	0.00272	CcSEcCtD
Fluorescein—Hypotension—Capecitabine—colon cancer	0.000344	0.00272	CcSEcCtD
Fluorescein—Erythema—Methotrexate—colon cancer	0.000336	0.00265	CcSEcCtD
Fluorescein—Nausea—Vincristine—colon cancer	0.000336	0.00265	CcSEcCtD
Fluorescein—Vomiting—Fluorouracil—colon cancer	0.000335	0.00264	CcSEcCtD
Fluorescein—Rash—Fluorouracil—colon cancer	0.000332	0.00262	CcSEcCtD
Fluorescein—Dermatitis—Fluorouracil—colon cancer	0.000332	0.00262	CcSEcCtD
Fluorescein—Paraesthesia—Capecitabine—colon cancer	0.000331	0.00261	CcSEcCtD
Fluorescein—Headache—Fluorouracil—colon cancer	0.00033	0.0026	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—colon cancer	0.000329	0.0026	CcSEcCtD
Fluorescein—Dyspnoea—Capecitabine—colon cancer	0.000328	0.00259	CcSEcCtD
Fluorescein—Nausea—Irinotecan—colon cancer	0.000327	0.00258	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Capecitabine—colon cancer	0.000318	0.00251	CcSEcCtD
Fluorescein—Pain—Capecitabine—colon cancer	0.000315	0.00248	CcSEcCtD
Fluorescein—Nausea—Fluorouracil—colon cancer	0.000313	0.00247	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—colon cancer	0.000312	0.00246	CcSEcCtD
Fluorescein—Feeling abnormal—Capecitabine—colon cancer	0.000304	0.00239	CcSEcCtD
Fluorescein—Malaise—Methotrexate—colon cancer	0.000303	0.00239	CcSEcCtD
Fluorescein—Gastrointestinal pain—Capecitabine—colon cancer	0.000301	0.00238	CcSEcCtD
Fluorescein—Cough—Methotrexate—colon cancer	0.000293	0.00231	CcSEcCtD
Fluorescein—Urticaria—Capecitabine—colon cancer	0.000293	0.00231	CcSEcCtD
Fluorescein—Abdominal pain—Capecitabine—colon cancer	0.000291	0.0023	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—colon cancer	0.000291	0.0023	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—colon cancer	0.000286	0.00226	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000284	0.00224	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—colon cancer	0.000283	0.00223	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—colon cancer	0.000274	0.00216	CcSEcCtD
Fluorescein—Hypersensitivity—Capecitabine—colon cancer	0.000271	0.00214	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—colon cancer	0.000269	0.00212	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—colon cancer	0.000266	0.0021	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—colon cancer	0.000265	0.00209	CcSEcCtD
Fluorescein—Asthenia—Capecitabine—colon cancer	0.000264	0.00208	CcSEcCtD
Fluorescein—Pruritus—Capecitabine—colon cancer	0.000261	0.00206	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—colon cancer	0.000256	0.00202	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—colon cancer	0.000246	0.00194	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—colon cancer	0.000244	0.00193	CcSEcCtD
Fluorescein—Dizziness—Capecitabine—colon cancer	0.000244	0.00192	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—colon cancer	0.000237	0.00187	CcSEcCtD
Fluorescein—Pain—Methotrexate—colon cancer	0.000234	0.00185	CcSEcCtD
Fluorescein—Vomiting—Capecitabine—colon cancer	0.000234	0.00185	CcSEcCtD
Fluorescein—Rash—Capecitabine—colon cancer	0.000232	0.00183	CcSEcCtD
Fluorescein—Dermatitis—Capecitabine—colon cancer	0.000232	0.00183	CcSEcCtD
Fluorescein—Headache—Capecitabine—colon cancer	0.000231	0.00182	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—colon cancer	0.000226	0.00178	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—colon cancer	0.000224	0.00177	CcSEcCtD
Fluorescein—Nausea—Capecitabine—colon cancer	0.000219	0.00173	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—colon cancer	0.000218	0.00172	CcSEcCtD
Fluorescein—Abdominal pain—Methotrexate—colon cancer	0.000217	0.00171	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—colon cancer	0.000202	0.00159	CcSEcCtD
Fluorescein—Asthenia—Methotrexate—colon cancer	0.000197	0.00155	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—colon cancer	0.000194	0.00153	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—colon cancer	0.000181	0.00143	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—colon cancer	0.000174	0.00138	CcSEcCtD
Fluorescein—Rash—Methotrexate—colon cancer	0.000173	0.00136	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—colon cancer	0.000173	0.00136	CcSEcCtD
Fluorescein—Headache—Methotrexate—colon cancer	0.000172	0.00136	CcSEcCtD
Fluorescein—Nausea—Methotrexate—colon cancer	0.000163	0.00128	CcSEcCtD
